Navigation Links
Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
Date:11/7/2008

NETTLETON, Miss., Nov. 7 /PRNewswire-FirstCall/ -- Universal Bioenergy, Inc. (Pink Sheets: UBRG) CEO, Dr. Richard Craven, stated, "Algae can become a prominent source of energy, and with several new algae technology companies emerging, it is a good time to form alliances. We have identified and spoken with some candidates but certainly welcome contact from interested parties. It is our goal to one day be 100% self-supplying in oil raw materials. Growing our own algae-based oil would be a step in that direction as it would reduce the influence of commodity price fluctuations on our operating costs."

Universal Bioenergy, Inc. is actively seeking relationships with algae production companies for the purpose of biodiesel and other fuel production.

About Universal Bioenergy Inc.

Universal Bioenergy, Inc. ( http://www.universalbioenergy.com ) is a Mississippi-based company trading under the symbol UBRG.otc. and is engaged in the production of renewable fuels through its subsidiary Universal Bioenergy North America, Inc. who operates a biodiesel refinery in Mississippi. The refinery intends to produce biodiesel fuel from various virgin vegetable oils, premium greases, and non-edible vegetable oil sources using their unique and economical process.

Safe Harbor: Universal is a developmental stage company with limited operating history. To date it has not generated a positive cash flow. Anyone considering purchasing securities of this company should review its filings with the Securities and Exchange Commission. Certain statements contained within this press release contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, including product releases and marketing efforts, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE Universal Bioenergy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
2. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
3. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
4. Carrington and Universal Harvest Sign Supply Agreement
5. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
6. SyntheMed Files Universal Shelf Registration
7. Raj Khankari Named Bioenergy, Inc., CEO
8. Osteotechs Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
9. NIU Seeks OK for New Proton Cancer Treatment and Research Center
10. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
11. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 /PRNewswire/ ... immune modulatory medicines, announced today the initiation of a ... candidate, LYC-30937- E nteric C oated, in patients ... that is estimated to affect as many as 7.5 million ... with approximately 1.5 - 3 million cases being diagnosed ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a ... point-of-care products for the objective detection of concussion and ... company has successfully completed a meeting with the U.S. ... Tbit™ blood test Pre-Submission Package. During the meeting company ... system as a precursor to commencement of a planned ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
Breaking Biology News(10 mins):